For example, pooled data from randomized controlled trials indicate that GLP-1 RAs can reduce AHI by approximately 5–16 events per hour, with greater improvements observed in individuals with higher baseline obesity (101, 102). The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.